tradingkey.logo

IRadimed Corp

IRMD
97.060USD
+0.460+0.48%
收盤 12/24, 13:00美東報價延遲15分鐘
1.23B總市值
58.23本益比TTM

IRadimed Corp

97.060
+0.460+0.48%

關於 IRadimed Corp 公司

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.

IRadimed Corp簡介

公司代碼IRMD
公司名稱IRadimed Corp
上市日期Jul 16, 2014
CEOSusi (Roger)
員工數量160
證券類型Ordinary Share
年結日Jul 16
公司地址12705 Ingenuity Drive
城市ORLANDO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編32826
電話14076778022
網址https://www.iradimed.com/
公司代碼IRMD
上市日期Jul 16, 2014
CEOSusi (Roger)

IRadimed Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
28.74K
-5.90%
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.16K
+239.42%
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.09K
+6.02%
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
5.98K
-0.25%
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Joe Kiani
Mr. Joe Kiani
Independent Director
Independent Director
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
28.74K
-5.90%
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.16K
+239.42%
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.09K
+6.02%
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
5.98K
-0.25%
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
MRI Compatible IV Infusion Pump Systems
8.19M
40.12%
MRI Compatible Patient Vital Signs Monitoring Systems
5.94M
29.13%
Disposables, services and other
5.20M
25.49%
Amortization of extended warranty agreements
592.45K
2.90%
Ferro Magnetic Detection Systems
482.20K
2.36%
地區USD
名稱
營收
佔比
United States
18.19M
89.13%
International
2.22M
10.87%
業務
地區
業務USD
名稱
營收
佔比
MRI Compatible IV Infusion Pump Systems
8.19M
40.12%
MRI Compatible Patient Vital Signs Monitoring Systems
5.94M
29.13%
Disposables, services and other
5.20M
25.49%
Amortization of extended warranty agreements
592.45K
2.90%
Ferro Magnetic Detection Systems
482.20K
2.36%

股東統計

更新時間: 11月14日 週五
更新時間: 11月14日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Susi (Roger E)
36.07%
Nine Ten Capital Management LLC
6.06%
BlackRock Institutional Trust Company, N.A.
5.26%
The Vanguard Group, Inc.
4.44%
Renaissance Technologies LLC
3.84%
其他
44.32%
持股股東
持股股東
佔比
Susi (Roger E)
36.07%
Nine Ten Capital Management LLC
6.06%
BlackRock Institutional Trust Company, N.A.
5.26%
The Vanguard Group, Inc.
4.44%
Renaissance Technologies LLC
3.84%
其他
44.32%
股東類型
持股股東
佔比
Individual Investor
36.79%
Investment Advisor/Hedge Fund
24.20%
Investment Advisor
21.09%
Hedge Fund
8.52%
Research Firm
2.03%
Pension Fund
1.50%
Bank and Trust
0.31%
Sovereign Wealth Fund
0.13%
Family Office
0.04%
其他
5.39%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
329
7.41M
58.27%
-960.52K
2025Q2
323
12.12M
95.27%
-1.02M
2025Q1
329
12.21M
96.19%
-859.52K
2024Q4
319
12.16M
95.93%
-668.30K
2024Q3
299
11.92M
94.09%
-356.11K
2024Q2
289
11.77M
92.95%
-163.43K
2024Q1
280
11.68M
92.20%
+22.27K
2023Q4
263
11.33M
89.87%
-741.29K
2023Q3
254
11.61M
92.13%
-662.68K
2023Q2
240
11.66M
92.58%
-250.35K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Susi (Roger E)
4.59M
36.07%
--
--
Apr 21, 2025
Nine Ten Capital Management LLC
872.00K
6.86%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
621.24K
4.88%
+12.94K
+2.13%
Jun 30, 2025
The Vanguard Group, Inc.
559.40K
4.4%
+6.58K
+1.19%
Jun 30, 2025
Renaissance Technologies LLC
491.81K
3.87%
-9.90K
-1.97%
Jun 30, 2025
Copeland Capital Management, LLC
457.92K
3.6%
-32.63K
-6.65%
Jun 30, 2025
Geode Capital Management, L.L.C.
261.39K
2.05%
+16.00K
+6.52%
Jun 30, 2025
BlackRock Financial Management, Inc.
260.47K
2.05%
-2.21K
-0.84%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
215.43K
1.69%
-4.75K
-2.16%
Jun 30, 2025
State Street Investment Management (US)
177.39K
1.39%
+1.71K
+0.97%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AAM Sawgrass US Small Cap Quality Growth ETF
2.83%
Ballast Small/Mid Cap ETF
1.19%
Fundamentals First ETF
0.92%
State Street SPDR S&P Health Care Equipment ETF
0.47%
Royce Quant Small-Cap Quality Value ETF
0.4%
Lattice Hartford Multifactor Small Cap ETF
0.39%
ALPS Barron's 400 ETF
0.27%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.25%
WisdomTree US SmallCap Quality Dividend Growth
0.18%
WisdomTree U.S. SmallCap Dividend Fund
0.17%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
佔比2.83%
Ballast Small/Mid Cap ETF
佔比1.19%
Fundamentals First ETF
佔比0.92%
State Street SPDR S&P Health Care Equipment ETF
佔比0.47%
Royce Quant Small-Cap Quality Value ETF
佔比0.4%
Lattice Hartford Multifactor Small Cap ETF
佔比0.39%
ALPS Barron's 400 ETF
佔比0.27%
SPDR SSGA US Small Cap Low Volatility Index ETF
佔比0.25%
WisdomTree US SmallCap Quality Dividend Growth
佔比0.18%
WisdomTree U.S. SmallCap Dividend Fund
佔比0.17%

分紅派息

近5年累計派現 39.46M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 13, 2025
IRMD.NB Interim Cash Dividend of gross USD 0.17 paid on Mar 05, 2025 going ex on Feb 24, 2025
Feb 24, 2025
Mar 05, 2025
Feb 24, 2025
Oct 31, 2024
IRMD.NB Final Cash Dividend of gross USD 0.15 paid on Nov 25, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 25, 2024
Nov 15, 2024
Aug 01, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Aug 30, 2024 going ex on Aug 20, 2024
Aug 20, 2024
Aug 30, 2024
Aug 20, 2024
May 02, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on May 30, 2024 going ex on May 17, 2024
May 20, 2024
May 30, 2024
May 17, 2024
Dec 12, 2023
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Jan 12, 2024 going ex on Dec 21, 2023
Dec 22, 2023
Jan 12, 2024
Dec 21, 2023

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

IRadimed Corp的前五大股東是誰?

IRadimed Corp的前五大股東如下:
Susi (Roger E)
持有股份:4.59M
佔總股份比例:36.07%。
Nine Ten Capital Management LLC
持有股份:872.00K
佔總股份比例:6.86%。
BlackRock Institutional Trust Company, N.A.
持有股份:621.24K
佔總股份比例:4.88%。
The Vanguard Group, Inc.
持有股份:559.40K
佔總股份比例:4.40%。
Renaissance Technologies LLC
持有股份:491.81K
佔總股份比例:3.87%。

IRadimed Corp的前三大股東類型是什麼?

IRadimed Corp 的前三大股東類型分別是:
Susi (Roger E)
Nine Ten Capital Management LLC
BlackRock Institutional Trust Company, N.A.

有多少機構持有IRadimed Corp(IRMD)的股份?

截至2025Q3,共有329家機構持有IRadimed Corp的股份,合計持有的股份價值約為7.41M,占公司總股份的58.27% 。與2025Q2相比,機構持股有所增加,增幅為-37.01%。

哪個業務部門對IRadimed Corp的收入貢獻最大?

在FY2025Q2,MRI Compatible IV Infusion Pump Systems業務部門對IRadimed Corp的收入貢獻最大,創收8.19M,占總收入的40.12% 。
KeyAI